白云山:拟出资14.98亿元参与设立广药基金二期

格隆汇
25 Jul

格隆汇7月25日|白云山公告,公司拟作为有限合伙人以自有资金出资14.98亿元,占广药基金二期认缴出资总额的99.90%。广药基金二期总规模为15亿元,管理人为广州广药资本私募基金管理有限公司,广药资本是公司控股股东广州医药集团有限公司持股80%的控股子公司。本次交易构成关联交易,但不构成重大资产重组。广药资本最近一年又一期的主要财务指标为:2025年6月30日/2025年1-6月,总资产...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10